Printout from Pearl Cohen Zedek Latzer Baratz

News / Jan 09, 2019

CytoReason Signs Agreement with Pfizer

Search By

  News & Publications

Congratulations to Yael Baratz's client CytoReason, who have entered into a Collaboration Agreement with Pfizer Inc.

CytoReason will potentially receive tens of millions of US$ for technology access fees, #research support and certain success-based payments. CytoReason is a leader in machine learning for drug discovery and development.

Their technology has to date yielded 2 pending patents, 10 commercial and scientific collaborations and 16 peer reviewed publications. 

For the full article, click HERE

 

Read these items